Currently representing Mylan in an ANDA litigation relating to formulation of pharmaceutical capsules for use in generic drugs. This case is currently pending and is set to go to trial in October 2017.

Allergan Sales, LLC, et al. v. Mylan Pharms. Inc., et al., Civ. No. 2:15-cv-1740 (E.D. Tex., filed November 9, 2015)

Experience Center

Match our Experience to Your Needs

Experience Highlights

Integration of Atlanta Cardiology Group P.C. into Piedmont Heart Institute, a subsidiary of the Piedmont Healthcare System
Represented Atlanta Cardiology Group P.C. with its integration from a large multi-office cardiology practice into Piedmont Heart more
Trademark infringement for a Fortune 500 multinational computer software manufacturer
Successfully represented a Fortune 500 multinational corporation that designs and manufactures consumer electronics and computer software more
Co-counsel to Tort Claimants' Committee in one of the largest mass tort Chapter 11 cases
The firm served as co-counsel to the Tort Claimants' Committee in one of largest mass tort Chapter 11 cases ever filed. A reorganization more
Rail agreement between two public transportation systems
Representing a regional public transportation authority in what will be a rail agreement between two public transportation systems. more